CCRM Boston Physician, Alison Zimon, M.D., Receives Recognition as One of Boston Magazine’s 2017 Top Doctors
Alison Zimon, M.D., co-founder and co-medical director of CCRM Boston, has been named a Boston Magazine “Top Doctor 2017” her exemplary accomplishments in the field of reproductive endocrinology. In a national survey coordinated by Castle Connolly, Dr. Zimon was selected as a highly skilled and exceptional doctor by her peers due to her caring and individualized care for each patient. The Top Doctor award helps educate and inform readers of the most experienced and accomplished physicians.
Dr. Alison Zimon is board certified in reproductive endocrinology and infertility, as well as obstetrics and gynecology. In addition to her role at CCRM Boston, Dr. Zimon is a clinical instructor in the department of obstetrics, gynecology and reproductive biology at Harvard Medical School and is a staff physician in obstetrics and gynecology at Beth Israel Deaconess Medical Center and Newton Wellesley Hospital.
She received her undergraduate degree from Harvard University and her medical degree from Yale University School of Medicine. Dr. Zimon completed her residency for obstetrics and gynecology and fellowship training in reproductive endocrinology and infertility at Harvard Medical School/Beth Israel Deaconess Medical Center. Dr. Zimon is on the national Resolve Physicians Council, the Executive Board of the New England Fertility Society, the Practice Bulletin Committee of the American College of Obstetrics and Gynecology, and is an active member of the American Society of Reproductive Medicine.
In addition to being named a Boston Magazine “Top Doctor 2017,” Dr. Zimon has received numerous awards and honors for clinical excellence and compassionate care, including Boston SuperDoctors, Patients’ Choice Award, On-Time Doctor Award, Compassionate Doctor Award, Leading Physicians of the World, and the Schwartz Center Compassionate Caregiver Award.
For details of the Top Doctor award selection process, visit Boston Magazine.